MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase
about
Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma CellsMechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineAccounting for the delay in the transition from acute to chronic pain: axonal and nuclear mechanismsMDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection.Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor.Effects of stress and MDMA on hippocampal gene expression.MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment.Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.Chronic voluntary oral methamphetamine induces deficits in spatial learning and hippocampal protein kinase Mzeta with enhanced astrogliosis and cyclooxygenase-2 levels.
P2860
Q28553620-07D926C3-F899-451D-85DD-15789B15C6E7Q30387357-26C3532F-C298-48C5-BB3F-CA8B46EECD53Q30417935-1ADEBC63-C21A-45BB-B91D-5BC5AB35F306Q34946158-ECEC7CB6-04F0-4686-837B-444134FFBC69Q35940652-694439E9-5E2B-41F0-9E87-A1D3A30368A6Q36586296-46D2DDDA-357A-4C7C-8B41-8F7DD87A9257Q36845234-89D4918A-DC93-465F-8D6E-1C21EEE7E045Q37342183-DAEEA565-4BFC-4722-A8BD-8ACD7C3F74C0Q40977003-1CF84F8E-D578-4E45-AF3B-3E48FC7584D1Q41907090-DD2EE03F-F2ED-4674-9177-ABA5A4F92FBBQ47150497-90521569-C131-429C-8D29-B7BD8697632EQ48122131-0D91414C-D4B4-49F6-921D-EA2DC63DB77CQ48302266-ED5EB711-4195-4E69-8AAC-F5E0CF376CB9Q52316669-A170C515-153B-4783-984F-680D15646D1F
P2860
MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@ast
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@en
type
label
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@ast
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@en
prefLabel
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@ast
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@en
P2093
P2860
P1476
MDMA increases glutamate relea ...... he rat: role of cyclooxygenase
@en
P2093
Bryan K Yamamoto
Gary A Gudelsky
Jacobi I Cunningham
John H Anneken
Stuart A Collins
P2860
P2888
P356
10.1007/S11481-012-9420-X
P577
2012-11-18T00:00:00Z